A Study of TAS-303 in Female Patients With Stress Urinary Incontinence
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate pharmacological effect, safety and pharmacokinetic
of TAS-303 in female patients with Stress Urinary Incontinence.